Features of Psychotic Symptoms in Methamphetamine Use Disorder Patients and Ketamine Use Disorder Patients: A Cross-Sectional Study.
Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder.
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, Lee Y, Lui LMW, Mansur RB, Papakostas GI, Subramaniapillai M, Thase M, Vieta E, Young AH, Zarate CA Jr, Stahl S.
Am J Psychiatry. 2021 May 1;178(5):383-399. doi: 10.1176/appi.ajp.2020.20081251. Epub 2021 Mar 17.
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
Anand A, Mathew SJ, Sanacora G, Murrough JW, Goes FS, Altinay M, Aloysi AS, Asghar-Ali AA, Barnett BS, Chang LC, Collins KA, Costi S, Iqbal S, Jha MK, Krishnan K, Malone DA, Nikayin S, Nissen SE, Ostroff RB, Reti IM, Wilkinson ST, Wolski K, Hu B.
N Engl J Med. 2023 Jun 22;388(25):2315-2325. doi: 10.1056/NEJMoa2302399. Epub 2023 May 24.
Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses.
Fountoulakis KN, Tohen M, Zarate CA Jr.
Eur Neuropsychopharmacol. 2022 Jan;54:100-115. doi: 10.1016/j.euroneuro.2021.10.003.
Striatal dopamine mediates hallucination-like perception in mice.
Schmack K, Bosc M, Ott T, Sturgill JF, Kepecs A.
Science. 2021 Apr 2;372(6537):eabf4740. doi: 10.1126/science.abf4740.
Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial.
Abbar M, Demattei C, El-Hage W, Llorca PM, Samalin L, Demaricourt P, Gaillard R, Courtet P, Vaiva G, Gorwood P, Fabbro P, Jollant F.
BMJ. 2022 Feb 2;376:e067194. doi: 10.1136/bmj-2021-067194.
Bipolar depression: a major unsolved challenge.
Baldessarini RJ, Vázquez GH, Tondo L.
Int J Bipolar Disord. 2020 Jan 6;8(1):1. doi: 10.1186/s40345-019-0160-1.
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.
McCutcheon RA, Krystal JH, Howes OD.
World Psychiatry. 2020 Feb;19(1):15-33. doi: 10.1002/wps.20693.
Esketamine for treatment-resistant depression: A review of clinical evidence (Review).
Vasiliu O.
Exp Ther Med. 2023 Jan 25;25(3):111. doi: 10.3892/etm.2023.11810. eCollection 2023 Mar.
Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).
Ekstrand J, Fattah C, Persson M, Cheng T, Nordanskog P, Åkeson J, Tingström A, Lindström MB, Nordenskjöld A, Movahed Rad P.
Int J Neuropsychopharmacol. 2022 May 27;25(5):339-349. doi: 10.1093/ijnp/pyab088.
Ketamine-Induced Hallucinations.
Powers AR 3rd, Gancsos MG, Finn ES, Morgan PT, Corlett PR.
Psychopathology. 2015;48(6):376-85. doi: 10.1159/000438675. Epub 2015 Sep 12.
